Relationship between patient costs and patient pathways.

Area of Science:

• Health services research
• Oncology
• Health economics

Background:

• Patient pathways in healthcare are increasingly scrutinized for efficiency.
• Understanding actual patient journeys is crucial for effective cost management in cancer care.

Purpose of the Study:

• To identify and analyze real-world (as-is) patient pathway variations in breast cancer care.
• To investigate the correlation between these actual pathways and patient-incurred costs.

Main Methods:

• Employed mixed-methods approach: quantitative (event-log data mining, statistical analysis) and qualitative (expert interviews).
• Utilized data from Swedish breast cancer quality registry and case-costing systems across four hospital groups.

Main Results:

• Unique patient pathways, followed by only one patient, were often more costly.
• Confirmed lower costs with frequent pathways for mastectomy patients, but found inconclusive results for partial mastectomy groups.
• Observed the highest pathway variation among breast cancer patients undergoing chemotherapy.

Conclusions:

• The assumption that standardized patient pathways universally reduce costs needs re-evaluation based on actual clinical practice.
• Analyzing as-is patient pathways offers deeper insights into cost determinants than focusing solely on idealized to-be pathways.
• Highlights the critical role of data-driven research in understanding complex healthcare costs.